1. Magill, SS, O’Leary, E, Janelle, SJ, et al. Changes in prevalence of health care–associated Infections in U.S. Hospitals. N Engl J Med 2018; 379: 1732–1744.
Google Scholar | Crossref | Medline2. Ma, GK, Brensinger, CM, Wu, Q, et al. Increasing incidence of multiply recurrent Clostridium difficile infection in the United States: a cohort study incidence of multiply recurrent c difficile infection in the United States. Ann Intern Med 2017; 167: 152–158.
Google Scholar | Crossref | Medline3. Khanna, S, Pardi, DS, Aronson, SL, et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol 2011; 107: 89–95.
Google Scholar | Crossref | Medline | ISI4. Carroll, KC. Tests for the diagnosis of Clostridium difficile infection: the next generation. Anaerobe 2011; 17: 170–174.
Google Scholar | Crossref | Medline | ISI5. Gupta, A, Khanna, S. Repeat Clostridium difficile testing. JAMA 2016; 316: 2422–2423.
Google Scholar | Crossref | Medline6. Polage, CR, Gyorke, CE, Kennedy, MA, et al. Overdiagnosis of Clostridium difficile infection in the molecular test era. JAMA Intern Med 2015; 175: 1792–1801.
Google Scholar | Crossref | Medline7. Lessa, FC, Mu, Y, Bamberg, WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015; 372: 825–834.
Google Scholar | Crossref | Medline | ISI8. Abujamel, T, Cadnum, JL, Jury, LA, et al. Defining the vulnerable period for re-establishment of Clostridium difficile colonization after treatment of C difficile infection with oral vancomycin or metronidazole. PLoS One 2013; 8: e76269.
Google Scholar | Crossref | Medline9. Aichinger, E, Schleck, CD, Harmsen, WS, et al. Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay. J Clin Microbiol 2008; 46: 3795–3797.
Google Scholar | Crossref | Medline10. Durovic, A, Widmer, AF, Frei, R, et al. Distinguishing Clostridium difficile recurrence from reinfection: independent validation of current recommendations. Infect Control Hosp Epidemiol 2017; 38: 891–896.
Google Scholar | Crossref | Medline11. Kamboj, M, Khosa, P, Kaltsas, A, et al. Relapse versus reinfection: surveillance of Clostridium difficile infection. Clin Infect Dis 2011; 53: 1003–1006.
Google Scholar | Crossref | Medline | ISI12. Marsh, JW, Arora, R, Schlackman, JL, et al. Association of relapse of Clostridium difficile disease with BI/NAP1/027. J Clin Microbiol 2012; 50: 4078–4082.
Google Scholar | Crossref | Medline | ISI13. von Elm, E, Altman, DG, Egger, M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 2007; 147: 573–577.
Google Scholar | Crossref | Medline | ISI14. Cohen, SH, Tang, YJ, Silva, J Analysis of the pathogenicity locus in Clostridium difficile strains. J Infect Dis 2000; 181: 659–663.
Google Scholar | Crossref | Medline15. Sloan, LM, Duresko, BJ, Gustafson, DR, et al. Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection. J Clin Microbiol 2008; 46: 1996–2001.
Google Scholar | Crossref | Medline | ISI16. Carter, GP, Douce, GR, Govind, R, et al. The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile. PLoS Pathog 2011; 7: e1002317.
Google Scholar | Crossref | Medline17. Verdoorn, BP, Orenstein, R, Rosenblatt, JE, et al. High prevalence of tcdC deletion-carrying Clostridium difficile and lack of association with disease severity. Diagn Microbiol Infect Dis 2010; 66: 24–28.
Google Scholar | Crossref | Medline | ISI18. McDonald, LC, Gerding, DN, Johnson, S, et al. Clinical Practice Guidelines for Clostridium difficile infection in adults and children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018; 66: e1–e48.
Google Scholar | Crossref19. Saha, S, Khanna, S. Management of Clostridioides difficile colitis: insights for the gastroenterologist. Therap Adv Gastroenterol 2019; 12: 1–15.
Google Scholar | SAGE Journals20. Gerding, DN, Meyer, T, Lee, C, et al. Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C difficile infection: a randomized clinical trial. JAMA 2015; 313: 1719–1727.
Google Scholar | Crossref | Medline21. Crobach, MJT, Vernon, JJ, Loo, VG, et al. Understanding Clostridium difficile colonization. Clin Microbiol Rev 2018; 31: e00021-17.
Google Scholar | Crossref | Medline